Given that many of the risk factors for COVID-19 are age-related, a compelling argument can be made that those infected are suffering from an aging-related disease, no matter how old they are. A review published in Med encourages researchers studying metabolism and immunity to turn their attention to ketone bodies, which are being widely studied for their role in aging, as a possible therapeutic against COVID-19, seasonal flu and other respiratory infections.
Source: Researchers outline strategy for testing ketone bodies against COVID-19